ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Maryland » Geriatric Medicine

Top Geriatric Medicine Prescribers in Maryland

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MANZAR SHAFI M.D.

Geriatric Medicine

20,054

$954K

539
475 are 65+

11%
patients receiving schedule two controlled substances

Avg: 7%

14%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 24%

$48
Average prescription price

Avg: $59

JOSJIN VAZHAPPILLY

Geriatric Medicine

15,213

$746K

261
230 are 65+

20%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 24%

$49
Average prescription price

Avg: $59

ERNESTINE WRIGHT M.D.

Geriatric Medicine

14,575

$647K

378
368 are 65+

8%
patients receiving schedule two controlled substances

Avg: 7%

9%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 24%

$44
Average prescription price

Avg: $59

NURUL CHOWDHURY M.D.

Geriatric Medicine

13,597

$850K

224
165 are 65+

27%
patients receiving schedule two controlled substances

Avg: 7%

9%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 24%

$63
Average prescription price

Avg: $59

MARCELINO ALBUERNE M.D.

Geriatric Medicine

10,716

$757K

439
369 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

5%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 24%

$71
Average prescription price

Avg: $59

ROBERT COOPER M.D.

Geriatric Medicine

8,903

$536K

368
335 are 65+

7%
patients receiving schedule two controlled substances

Avg: 7%

4%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 24%

$60
Average prescription price

Avg: $59

MING YI MD

Geriatric Medicine

8,698

$441K

211
202 are 65+

20%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

33%
prescriptions for brand name drugs

Avg: 24%

$51
Average prescription price

Avg: $59

NANDAKUMAR VELLANKI MD

Geriatric Medicine

8,016

$570K

217
172 are 65+

8%
patients receiving schedule two controlled substances

Avg: 7%

5%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 24%

$71
Average prescription price

Avg: $59

ANNA MONIAS

Geriatric Medicine

7,963

$363K

402
402 are 65+

16%
patients receiving schedule two controlled substances

Avg: 7%

4%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 24%

$46
Average prescription price

Avg: $59

SUNIL RAJANI M.D.

Geriatric Medicine

7,640

$486K

201
170 are 65+

18%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 24%

$64
Average prescription price

Avg: $59

AARON CHARLES M.D.

Geriatric Medicine

7,638

$339K

199
192 are 65+

18%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 24%

$44
Average prescription price

Avg: $59

LEENA KODALI M.D.

Geriatric Medicine

7,272

$397K

185
167 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 24%

$55
Average prescription price

Avg: $59

SIMON SCALIA MD

Geriatric Medicine

6,821

$449K

364
308 are 65+

8%
patients receiving schedule two controlled substances

Avg: 7%

11%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 24%

$66
Average prescription price

Avg: $59

BARRY ROSENBAUM MD

Geriatric Medicine

6,207

$450K

379
341 are 65+

7%
patients receiving schedule two controlled substances

Avg: 7%

5%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 24%

$73
Average prescription price

Avg: $59

EDDIE NAKHUDA M.D., CMD, FACP

Geriatric Medicine

5,906

$229K

124
124 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

17%
prescriptions for brand name drugs

Avg: 24%

$39
Average prescription price

Avg: $59

SCOTT MAURER M.D.

Geriatric Medicine

5,816

$499K

334
311 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

9%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 24%

$86
Average prescription price

Avg: $59

ROY FRIED M.D.

Geriatric Medicine

5,707

$383K

146
145 are 65+

12%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 24%

$67
Average prescription price

Avg: $59

ANWAR MUNSHI

Geriatric Medicine

5,473

$319K

235
179 are 65+

14%
patients receiving schedule two controlled substances

Avg: 7%

11%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 24%

$58
Average prescription price

Avg: $59

ATCHUTHA GEETHA CHAN CHILAKAMARRI MD

Geriatric Medicine

5,399

$261K

263
258 are 65+

11%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 24%

$48
Average prescription price

Avg: $59

RUBEN REIDER M.D.

Geriatric Medicine

5,021

$337K

230
182 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 24%

$67
Average prescription price

Avg: $59

RICHARD FELDMAN MD

Geriatric Medicine

4,913

$370K

257
217 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

9%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 24%

$75
Average prescription price

Avg: $59

SHYAMSUNDAR RAJAN MD

Geriatric Medicine

4,629

$302K

196
156 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 24%

$65
Average prescription price

Avg: $59

ALAN HALLE MD

Geriatric Medicine

4,609

$308K

690
612 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

3%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 24%

$67
Average prescription price

Avg: $59

FARAH BOZORGI M.D.

Geriatric Medicine

4,519

$329K

119
80 are 65+

18%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 24%

$73
Average prescription price

Avg: $59

W. ANTHONY RILEY M.D.

Geriatric Medicine

4,260

$193K

130
109 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 24%

$45
Average prescription price

Avg: $59

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank